{"id":"W4232846302","doi":"10.4161/mabs.1.5.9675","title":"Letter from the Editor","year":2009,"lang":"en","type":"letter","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Golimumab; Tocilizumab; Biosimilar; Psoriatic arthritis; Ustekinumab; Food and drug administration; Abatacept; Tofacitinib; Canakinumab; Secukinumab; Rheumatoid arthritis; Family medicine; Rituximab; Internal medicine; Etanercept; Pharmacology; Adalimumab; Immunology; Antibody; Anakinra","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001112528,0.0008902145,0.001001096,0.0005501825,0.002124611,0.002140411,0.001327354,0.01950091,0.01595839],"category_scores_gemma":[0.01024289,0.000418861,0.0008819679,0.0003589214,0.0009701424,0.002507073,0.0007420399,0.01629084,0.01028064],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002116092,"about_ca_system_score_gemma":0.002011217,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001583683,"about_ca_topic_score_gemma":0.002218766,"domain_scores_codex":[0.9990475,0.0002278306,0.0001031518,0.0001806398,0.0002836464,0.0001572521],"domain_scores_gemma":[0.9980218,0.0006633226,0.0001183028,0.00005741671,0.0007149446,0.0004242597],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002898571,0.00002458451,0.0002068651,0.00003753258,0.000005944841,0.003796773,0.00004024052,0.00003531362,0.00007942496,0.0007440369,0.9884778,0.0065226],"study_design_scores_gemma":[0.00006120491,0.00005249337,0.0007137393,0.0001913788,0.00001562643,0.01161328,0.000231845,0.0002502232,0.000198382,0.002452254,0.9841908,0.00002880555],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.0009712597,0.003834418,0.0001818596,0.8546113,0.1271725,0.00003657806,0.00008872509,0.00008578389,0.01301758],"genre_scores_gemma":[0.009028474,0.004173371,0.0003309781,0.8398691,0.1086772,0.00005624553,0.00006804775,0.00004318919,0.03775338],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.01950091,"threshold_uncertainty_score":0.05338615,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02589655063744739,"score_gpt":0.2931476621074551,"score_spread":0.2672511114700077,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}